Prepare for your visit
Shelly Williams
Psychiatric/Mental Health (Nurse Practitioner) · Fulshear, TX · NPI 1538680822
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$688.31
in general payments reported to CMS, 2019-2025 · $203 in 2025
The $203 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $155.28
- Boehringer Ingelheim Pharmaceuticals, INC. $97.96
- Otsuka Pharmaceutical Development & Commercialization, INC. $97.46
- Teva Pharmaceuticals USA, INC. $96.16
- Biohaven Pharmaceutical Holding Company LTD. $52.60
- Astrazeneca Pharmaceuticals LP $48.58
Drugs and devices associated with these payments
Vraylar Spravato Rexulti Caplyta Azstarys
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Shelly Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10709197/shelly-williams